Exhaled Carbon Monoxide as a Marker of Hemolysis in Sickle Cell Disease- an Exploratory Study
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01888614 |
|
Recruitment Status :
Withdrawn
(Unable to secure equipment to proceed)
First Posted : June 28, 2013
Last Update Posted : December 23, 2016
|
Sponsor:
University Hospitals Cleveland Medical Center
Information provided by (Responsible Party):
Jane Little, University Hospitals Cleveland Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Actual Primary Completion Date : | December 2016 |
| Actual Study Completion Date : | December 2016 |